The new investors will acquire Stockholm, Sweden-based Envirotainer from Cinven and Novo Holdings, supporting its expansion in core markets and APAC.
The investment will also expand its newly launched CryoSure service, invest in new technologies, and roll out its third generation Releye platform.
Peter Gisel-Ekdahl, CEO of Envirotainer, says, “This long-term partnership will strengthen Envirotainer and help us deliver on our purpose of enabling access to life-saving pharmaceuticals. At the same time, this investment, from such esteemed investors, confirms the strength of Envirotainer's business model and the company's very exciting future.”
Camilla Macapili Languille, Head of Life Sciences at Mubadala, adds, “Their extensive international footprint ideally positions Envirotainer to meet the pharma industry's growing need for global temperature-controlled distribution and as the undisputed market leader, they are continuing to pioneer developments in the sector with forward-thinking R&D innovation. We have strong conviction in the company's growth trajectory and will work closely with management and our partners at EQT to ensure its long-term success.”